Provided by Tiger Trade Technology Pte. Ltd.

Marker Therapeutics, Inc.

1.39
+0.170013.93%
Post-market: 1.37-0.0200-1.44%17:39 EDT
Volume:99.37K
Turnover:136.54K
Market Cap:23.18M
PE:-2.89
High:1.44
Open:1.25
Low:1.25
Close:1.22
52wk High:2.46
52wk Low:0.8099
Shares:16.67M
Float Shares:14.12M
Volume Ratio:1.11
T/O Rate:0.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4806
EPS(LYR):-0.7945
ROE:-76.87%
ROA:-44.14%
PB:1.91
PE(LYR):-1.75

Loading ...

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 19

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 17

Marker Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 15

Marker Therapeutics Q2 FY26 Net Loss Narrows 55% to USD 1.83 Million

Reuters
·
Aug 15

Marker Therapeutics Inc Expected to Post a Loss of 22 Cents a Share - Earnings Preview

Reuters
·
Aug 11

Analysts Are Bullish on These Healthcare Stocks: Marker Therapeutics (MRKR), Tenax Therapeutics (TENX)

TIPRANKS
·
Jul 10

Marker Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 16

Marker Therapeutics Q1 FY26 net loss narrows 28% to USD 3.18 million

Reuters
·
May 16

Marker Therapeutics Inc expected to post a loss of 18 cents a share - Earnings Preview

Reuters
·
May 12

Marker Therapeutics shareholders approved charter amendment boosting authorized common stock to 130 million shares

Reuters
·
May 05

BRIEF-Marker Therapeutics FY Basic EPS USD -0.79

Reuters
·
Mar 19

Marker Therapeutics FY Net Income USD -12.2 Million

THOMSON REUTERS
·
Mar 19

Press Release: Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results

Dow Jones
·
Mar 19

Marker Therapeutics FY 2025 net loss widens 13% to USD 12.16 million as grant income falls 46% to USD 3.55 million

Reuters
·
Mar 19

Marker Therapeutics Inc. Announces Annual Stockholder Meeting Notice

Reuters
·
Mar 11

H.C. Wainwright Sticks to Its Buy Rating for Marker Therapeutics (MRKR)

TIPRANKS
·
Mar 10